Author

B. D. Hudson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

G. Milligan· 3 shared A. B. Tobin· 2 shared L. Jenkins· 2 shared A. Boufersaoui· 1 shared C. Molloy· 1 shared D. A. Tennant· 1 shared D. Bolognini· 1 shared D. Calebiro· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

G. Milligan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A new paradigm of intracrine free fatty acid receptor 4 signaling at lipid droplets

D. Calebiro, S. L. O'Brien, E. Tripp, G. Smith, A. Boufersaoui, J. Roberts, J. A. Pike, J. Correia, T. A. Miljus, D. A. Tennant, B. D. Hudson, G. Milligan, Z. Gerhart-Hines, T. W. Schwartz

The paper shows FFA4, a GPCR, signals from lipid droplet-associated membranes in adipocytes, providing localized feedback to regulate lipolysis.

bioRxiv · Jul 28, 2023 · PreprintPharmacology & Toxicology

Phosphorylation of the M1 muscarinic acetylcholine receptor mediates protection in neurodegenerative disease

M. Scarpa, C. Molloy, L. Jenkins, G. S. Tejeda, M. Rossi, L. Dwomoh, S. Marsango, Z. Ahmed, G. Milligan, B. D. Hudson, A. B. Tobin, S. J. Bradley

This study shows that phosphorylation and arrestin-dependent signaling of the M1 muscarinic receptor provides neuroprotection in prion disease, suggesting potential for developing safer therapies for neurodegenerative diseases.

bioRxiv · Apr 29, 2021 · PreprintPharmacology & Toxicology

Chemogenetic analysis of how receptors for short chain fatty acids regulate the gut-brain axis

A. B. Tobin, N. Barki, D. Bolognini, U. Borjesson, L. Jenkins, J. Riddell, D. I. Hughes, T. Ulven, B. D. Hudson, E. R. Ulven, N. Dekker, G. Milligan

This study identifies a specific agonist for a modified FFA2 receptor and demonstrates distinct roles of FFA2 and FFA3 in gut-brain communication using genetically engineered mice.

bioRxiv · Jan 11, 2020Pharmacology & Toxicology